Articles related to BIOMARKERS

Research demonstrates earwax contains biological markers that can discriminate between cancer patients and healthy individuals with complete accuracy, while glucose monitoring through earwax shows enhanced precision over standard blood testing methods.

Blood biomarker testing offers 91.7% accuracy in detecting amyloid plaques while providing more accessible alternative to cerebrospinal fluid analysis, though confirmation via PET or CSF remains necessary for indeterminate results.

You could have a patient with an LDL-C of 100 mg/dL and think they’re in the clear, but if their LDL-P is sky-high, they’re still at risk for plaque formation.

p-Tau217 demonstrates superior diagnostic accuracy among fluid biomarkers for detecting amyloid beta pathology, offering a noninvasive approach to early Alzheimer’s detection.

Blood-based mitochondrial DNA testing could provide a less invasive alternative to spinal taps for Parkinson’s diagnosis, with implications for earlier intervention and treatment.

Latest clinical trial data suggests active monitoring may be a viable alternative to standard treatment for select low-risk DCIS patients, with comparable quality-of-life outcomes.